(Journal of Nutrition. 2000;130:1023S-1025S.)
© 2000 The American Society for Nutritional Sciences
Supplement
Brain Uptake of Glutamate: Food for Thought1 ,2
David Attwell
Department of Physiology, University College London, England
 |
ABSTRACT
|
|---|
Glutamate transporters in cells of the central nervous system play a
key role, not only in providing glutamate for metabolic and protein
synthesis purposes, but also in terminating glutamates synaptic
actions and keeping the extracellular glutamate concentration below
levels that cause neuronal death. Recent advances in our understanding
of how glutamate transport is powered allow a prediction of how
glutamate transport will fail in stroke, releasing excess glutamate
that triggers the death of neurons, thereby causing mental and physical
handicap.
KEY WORDS: glutamate brain uptake stroke
 |
INTRODUCTION
|
|---|
The transmission of information at most excitatory synapses in the brain
is mediated by the release of glutamate from the presynaptic cell.
After diffusing to the postsynaptic cell, glutamate activates cation
channels or G proteinlinked receptors, which alters the membrane
potential or intracellular biochemistry of the postsynaptic cell. For
brain neurons to transmit information at a high rate, it is necessary
for glutamates postsynaptic actions to be terminated rapidly. This
occurs in part by removal of glutamate from the extracellular space by
glutamate transporters. These transporters also have the role of
keeping the extracellular glutamate concentration
([glu]o) below levels that are excitotoxic to
neurons. That is, if [glu]o rises too high for
too long, then excessive activation of postsynaptic
N-methyl-D-aspartate
(NMDA)3
receptors causes an excessive calcium influx into neurons, which
triggers their death (Ankarcrona et al. 1995
,
Choi et al. 1988
). In this article, I will discuss how
glutamate transporters function normally, and how they malfunction in
brain ischemia.
 |
Types and locations of glutamate transporters
|
|---|
Five different mammalian glutamate transporters have been cloned.
Their names and the cells in which they are expressed are shown in
Figure 1
. Apart from cells in the retina and cerebellum, which express high
levels of the tissue-specific transporters listed in Figure 1
, the
transporters expressed most commonly throughout the brain are
GLT-1/EAAT2 in glial cells and EAAC1/EAAT3 in neurons.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1. The names of the glutamate transporter family members, and their
location in the brain. The excitatory amino acid transporter (EAAT)
names are for the human transporters; other names were given when the
transporters were first cloned in nonhuman species. Abbreviations:
GLAST, glutamate and aspartate transporter; GLT, glutamate transporter;
EAAC, excitatory amino acid carrier.
|
|
 |
Powering glutamate transport
|
|---|
The extracellular concentration of glutamate is usually in the low
micromolar range, whereas that inside cells is in the millimolar range.
Furthermore, the potential inside cells is negative, and glutamate
bears a net negative charge. Thus, energy is required to pump glutamate
into cells up its electrochemical gradient. This energy does not come
directly from ATP, but is derived from the cotransport of ions moving
down their electrochemical gradients, as schematized in Figure 2
. Figure 2
shows that net positive charge enters the cell with each
glutamate, allowing glutamate transport to be monitored as a membrane
current (Fig. 3
; Brew and Attwell 1987
).

View larger version (19K):
[in this window]
[in a new window]
|
Figure 2. The ion movements powering uptake of glutamate into the cell. Three
Na+ and one H+ enter, while one K+
is transported out of the cell.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Figure 3. Schematic diagram of recording of glutamate transport in a glial cell
(wine glassshaped object) as a membrane current. A whole-cell
pipette (right) is attached to the cell, allowing
recording of an inward current (I: bottom right inset)
when glutamate is applied and activates the ion movements shown on the
transporter (black circle).
|
|
When a nontransported blocker of glutamate transport is applied, a
current change is seen that reflects the direction of glutamate
transport, i.e., outward at very negative potentials where inward
glutamate transport generates an inward current (before the blocker is
applied), and inward at very positive potentials where outward
glutamate transport generates an outward current (Zerangue and Kavanaugh 1996
). At some intermediate potential (the reversal
potential), there is no net transport, and applying the blocker
generates no current. This reversal potential is set by the number and
identity of the ions cotransported to drive glutamate transport.
Measurement of the reversal potential, and how it is altered by changes
of ion concentration, has revealed that for both the neuronal
transporter EAAT3 and the glial transporter GLT-1, three
Na+ ions and one H+ ion
enter the cell with each glutamate, and one K+
ion is transported out of the cell (Fig. 2
: Levy et al. 1998
, Zerangue and Kavanaugh 1996).
It is clear from Figure 2
that glutamate uptake is critically dependent
on the ion gradients that make favorable the entry of
Na+ and H+ into the cell.
Below, I will discuss what happens when this situation is not
maintained.
 |
Anion channel opening associated with glutamate transport
|
|---|
Glutamate transporters generate current by virtue of the net
charge entry that occurs as a result of the ion movements coupled to
glutamate movement. However, in addition, recent work has shown that
glutamate transport leads to the opening of an anion channel
(Wadiche et al. 1995
). Movement of
Cl- ions through this conductance generates a
particularly large current for the transporter EAAT4 expressed in
cerebellar Purkinje cells (Fairman et al. 1995
) and for
the transporter EAAT5 expressed in retinal photoreceptors and bipolar
cells (Arriza et al. 1997
, Eliasof et al. 1998
, Grant and Dowling 1995
, Sarantis et al. 1988
). In the retinal cells, the EAAT5 anion conductance
generates glutamate-gated voltage changes that are large enough to
contribute to the cells responses to light. For all of the other
transporters, however, the current flow through the anion conductance
is too small to affect the cells membrane potential, and the
functional significance of the anion conductance is uncertain.
 |
Reversal of glutamate uptake in brain ischemia
|
|---|
An inevitable consequence of the dependence of glutamate uptake on
transmembrane ionic gradients is that uptake will fail if those
gradients run down. This happens dramatically in brain ischemia or
hypoxia (Attwell et al. 1993
, Szatkowski and Attwell 1994
; Rossi et al. 2000
). A few minutes
after the onset of an occlusive stroke, which cuts off the blood supply
to an area of brain, there is a dramatic alteration in the
transmembrane ion gradients. The extracellular potassium concentration,
[K+]o, is usually
maintained at ~3 mmol/L by the
Na+/K+ pump transporting
K+ into cells. But after this pumps ATP supply
is removed, [K+]o rises
to 60 mmol/L and [Na+]o
falls by a similar amount. The
[K+]o rise depolarizes
cells to -20 mV, and this anoxic depolarization terminates information
processing by the affected area of brain.
The rise of [K+]o, fall
of [Na+]o, and
concomitant fall of
[K+]i, rise of
[Na+]i and membrane
depolarization, all decrease the energy available to power glutamate
uptake. Consequently glutamate transporters are expected to reverse and
pump glutamate out of cells into the extracellular space.
Figure 4
shows a diagram of an experiment to measure this reversed uptake.
Glutamate release from a glial cell, whole-cell clamped with
glutamate and Na+ inside, is sensed by
positioning a whole-cell clamped neuron nearby and using the
neurons glutamate-gated ion channels to detect the glutamate.
When the glial cell is depolarized in high
[K+]o solution, to mimic
the conditions of ischemia, glutamate release is detected by the
sensing neuron (Billups and Attwell 1996
,
Szatkowski et al. 1990
).

View larger version (15K):
[in this window]
[in a new window]
|
Figure 4. Schematic diagram of detection of glutamate release by reversed uptake
in conditions mimicking stroke. A glial cell (wine glassshaped
object) is whole-cell clamped with an electrode containing
glutamate and Na+ (right). Depolarizing the
glial cell potential (VM: bottom right
inset) in high [K+]o solution
activates reversed uptake, which can be measured as an outward current
flowing through the right pipette because of the ion movements on the
reversed transporter (black circle). At the same time a whole-cell
clamped neuron (snail-shaped object on left) with glutamate-gated
Na+-permeable channels in its membrane is positioned near
the glial cell. Glutamate leaving the glial cell is detected by opening
of channels and inward current flow (bottom left inset)
in the neuron.
|
|
Detailed calculations (Billups et al. 1998
) predict that
the ion concentration changes occurring in ischemia will result
automatically in reversed operation of glutamate transporters occurring
until [glu]o rises to ~60
µmol/L, a level known to trigger the death of neurons.
Microdialysis experiments on intact brain confirm this idea
(Wahl et al. 1994
). Because this rise of
[glu]o is determined solely by the ionic
stoichiometry of the transport process, the prospects for blocking this
glutamate release therapeutically are slim. Release can be slowed,
indeed it is slowed > 90% (Billups and Attwell 1996
, Takahashi et al. 1997
) by the brain
acidification that occurs in stroke (resulting from the switch to
anaerobic metabolism); eventually, however, it will still raise
[glu]o to a neurotoxic level. For this reason
the best outlook for stroke therapy involves the blockade of
glutamates actions on its receptors, as well as of the downstream
consequences of this receptor activation.
 |
FOOTNOTES
|
|---|
1 Presented at the International Symposium on
Glutamate, October 1214, 1998 at the Clinical Center for Rare
Diseases Aldo e Cele Daccó, Mario Negri Institute
for Pharmacological Research, Bergamo, Italy. The symposium was
sponsored jointly by the Baylor College of Medicine, the Center for
Nutrition at the University of Pittsburgh School of Medicine, the
Monell Chemical Senses Center, the International Union of Food Science
and Technology, and the Center for Human Nutrition; financial support
was provided by the International Glutamate Technical Committee. The
proceedings of the symposium are published as a supplement to
The Journal of Nutrition. Editors for the symposium
publication were John D. Fernstrom, the University of Pittsburgh School
of Medicine, and Silvio Garattini, the Mario Negri Institute for
Pharmacological Research. 
2 Supported by the Wellcome Trust, MRC and
European Community. 
3 Abbreviations used: EAAC, excitatory amino acid
carrier; EAAT, excitatory amino acid transporter; GLT, glutamate
transporter; NMDA, N-methyl-D-aspartate. 
 |
REFERENCES
|
|---|
1.
Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15:961-973[Medline]
2.
Arriza J. L., Eliasof S., Kavanaugh M. P., Amara S. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 1997;94:4155-4160[Abstract/Free Full Text]
3.
Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron 1993;11:401-407[Medline]
4.
Billups B., Attwell D. Modulation of non-vesicular glutamate release by pH. Nature (Lond.) 1996;379:171-174[Medline]
5.
Billups B., Rossi D., Oshima T., Warr O., Takahashi M., Sarantis M., Szatkowski M., Attwell D. Physiological and pathological operation of glutamate transporters. Prog. Brain Res. 1998;116:45-57[Medline]
6.
Brew H., Attwell D. Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells. Nature (Lond.) 1987;327:707-709[Medline]
7.
Choi D. W., Koh J. Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 1988;8:185-196[Abstract]
8.
Eliasof S., Arriza J. L., Leighton B. H., Kavanaugh M. P., Amara S. G. Excitatory amino acid transporters of the salamander retina: identification, localization, and function. J. Neurosci. 1998;18:698-712[Abstract/Free Full Text]
9.
Fairman W. A., Vandenberg R. J., Arriza J. L., Kavanaugh M. P., Amara S. G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature (Lond.) 1995;375:599-603[Medline]
10.
Grant G. B., Dowling J. E. A glutamate-activated chloride current in cone-driven ON bipolar cells of the white perch retina. J. Neurosci. 1995;15:3852-3862[Abstract]
11.
Levy L. M., Warr O., Attwell D. Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a CHO cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 1998;18:9620-9628[Abstract/Free Full Text]
12.
Rossi D., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature (Lond.) 2000;403:316-321[Medline]
13.
Sarantis M., Everett K., Attwell D. A presynaptic action of glutamate at the cone output synapse. Nature (Lond.) 1988;332:451-453[Medline]
14.
Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994;17:359-365[Medline]
15.
Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature (Lond.) 1990;348:443-446[Medline]
16.
Takahashi M., Billups B., Rossi D., Sarantis M., Hamann M., Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 1997;200:401-409[Abstract]
17.
Wadiche J. I., Amara S. G., Kavanaugh M. P. Ion fluxes associated with excitatory amino acid transport. Neuron 1995;15:721-728[Medline]
18.
Wahl F., Obrenovitch T. P., Hardy A. M., Plotkine M., Boulu R., Symon L. Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency. J. Neurochem. 1994;63:1003-1011[Medline]
19.
Zerangue N., Kavanaugh M. P. Flux coupling in a neuronal glutamate transporter. Nature (Lond.) 1996;383:634-637[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
C. W. Leffler, L. Balabanova, A. L. Fedinec, C. M. Waters, and H. Parfenova
Mechanism of glutamate stimulation of CO production in cerebral microvessels
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H74 - H80.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by American Society for Nutrition